NASDAQ
Ensysce Biosciences, Inc. (ENSC) has a free cash flow growth of -129.44% as of Friday, May 29, 2026. This represents a 291.70% decrease compared to its 12-month average of -33.05%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.